152 related articles for article (PubMed ID: 35900323)
1. Cortisol-producing adenoma-related somatic mutations in unilateral primary aldosteronism with concurrent autonomous cortisol secretion: their prevalence and clinical characteristics.
Wu WC; Peng KY; Lu JY; Chan CK; Wang CY; Tseng FY; Yang WS; Lin YH; Lin PC; Chen TC; Huang KH; Chueh JS; Wu VC
Eur J Endocrinol; 2022 Oct; 187(4):519-530. PubMed ID: 35900323
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of PRKACA mutations in Chinese patients with adrenal lesions: a single-centre study.
Li X; Wang B; Tang L; Lang B; Zhang Y; Zhang F; Chen L; Ouyang J; Zhang X
Clin Endocrinol (Oxf); 2016 Dec; 85(6):954-961. PubMed ID: 27296931
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
Chen YJ; Peng KY; Chueh JS; Liao HW; Hsieh TY; Wu VC; Wang SM
Front Endocrinol (Lausanne); 2022; 13():816754. PubMed ID: 35399924
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism.
Lin JH; Peng KY; Kuo YP; Liu H; Tan CB; Lin YF; Chiu HW; Lin YH; Chen YM; Chueh JS; Wu VC
Endocr Relat Cancer; 2022 Jan; 29(2):59-69. PubMed ID: 34821221
[TBL] [Abstract][Full Text] [Related]
5. The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism.
Jiang Y; Zhou L; Zhang C; Su T; Jiang L; Zhou W; Zhong X; Wu L; Wang W
Front Endocrinol (Lausanne); 2024; 15():1369582. PubMed ID: 38745957
[TBL] [Abstract][Full Text] [Related]
6. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
Nakajima Y; Okamura T; Gohko T; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Ishii S; Tomaru T; Horiguchi K; Okada S; Takata D; Rokutanda N; Horiguchi J; Tsushima Y; Oyama T; Takeyoshi I; Yamada M
Endocr J; 2014; 61(8):825-32. PubMed ID: 25069672
[TBL] [Abstract][Full Text] [Related]
8. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
Rege J; Hoxie J; Liu CJ; Cash MN; Luther JM; Gellert L; Turcu AF; Else T; Giordano TJ; Udager AM; Rainey WE; Nanba K
J Clin Endocrinol Metab; 2022 Jan; 107(2):e594-e603. PubMed ID: 34534321
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of primary aldosteronism with concurrent adrenal Cushing's syndrome].
Guo JC; Chen XY; Zhang JQ; Guo XH
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2828-2833. PubMed ID: 32988142
[No Abstract] [Full Text] [Related]
10. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
12. New-onset diabetes mellitus risk associated with concurrent autonomous cortisol secretion in patients with primary aldosteronism.
Wu VC; Chan CK; Wu WC; Peng KY; Chang YS; Yeh FY; Chiang JY; Lee YJ; Liu KL; Wang SM; Lin YH; Chueh JS;
Hypertens Res; 2023 Feb; 46(2):445-455. PubMed ID: 36481967
[TBL] [Abstract][Full Text] [Related]
13. Discriminative Capacity of CT Volumetry to Identify Autonomous Cortisol Secretion in Incidental Adrenal Adenomas.
Olmos R; Mertens N; Vaidya A; Uslar T; Fernandez P; Guarda FJ; Zúñiga Á; San Francisco I; Huete A; Baudrand R
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1946-e1953. PubMed ID: 35020922
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study.
Deutschbein T; Reimondo G; Di Dalmazi G; Bancos I; Patrova J; Vassiliadi DA; Nekić AB; Debono M; Lardo P; Ceccato F; Petramala L; Prete A; Chiodini I; Ivović M; Pazaitou-Panayiotou K; Alexandraki KI; Hanzu FA; Loli P; Yener S; Langton K; Spyroglou A; Kocjan T; Zacharieva S; Valdés N; Ambroziak U; Suzuki M; Detomas M; Puglisi S; Tucci L; Delivanis DA; Margaritopoulos D; Dusek T; Maggio R; Scaroni C; Concistrè A; Ronchi CL; Altieri B; Mosconi C; Diamantopoulos A; Iñiguez-Ariza NM; Vicennati V; Pia A; Kroiss M; Kaltsas G; Chrisoulidou A; Marina LV; Morelli V; Arlt W; Letizia C; Boscaro M; Stigliano A; Kastelan D; Tsagarakis S; Athimulam S; Pagotto U; Maeder U; Falhammar H; Newell-Price J; Terzolo M; Fassnacht M
Lancet Diabetes Endocrinol; 2022 Jul; 10(7):499-508. PubMed ID: 35533704
[TBL] [Abstract][Full Text] [Related]
15. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
[TBL] [Abstract][Full Text] [Related]
16. Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.
Ohno Y; Sone M; Inagaki N; Takeda Y; Kurihara I; Tsuiki M; Ichijo T; Wada N; Katabami T; Ogawa Y; Okamura S; Fukuoka T; Kai T; Izawa S; Yoshikawa Y; Hashimoto S; Yamada M; Chiba Y; Naruse M;
J Clin Endocrinol Metab; 2019 Oct; 104(10):4382-4389. PubMed ID: 31058960
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
[TBL] [Abstract][Full Text] [Related]
18. Enhanced performance of a modified diagnostic test of primary aldosteronism in patients with adrenal adenomas.
Markou A; Kaltsas GA; Papanastasiou L; Gravvanis C; Voulgaris N; Kanti G; Zografos GN; Chrousos GP; Piaditis G
Eur J Endocrinol; 2022 Jan; 186(2):265-273. PubMed ID: 34882580
[TBL] [Abstract][Full Text] [Related]
19. Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success.
Peng KY; Liao HW; Chan CK; Lin WC; Yang SY; Tsai YC; Huang KH; Lin YH; Chueh JS; Wu VC
Hypertension; 2020 Nov; 76(5):1537-1544. PubMed ID: 32921192
[TBL] [Abstract][Full Text] [Related]
20. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
